David Ginsberg
AuthID: R-00F-EYD
1
TITLE: OnabotulinumtoxinA is Effective in Patients with Urinary Incontinence due to Neurogenic Detrusor Overactivity Regardless of Concomitant Anticholinergic Use or Neurologic Etiology (vol 30, pg 819, 2013) Full Text
AUTHORS: Ginsberg, D; Cruz, F ; Herschorn, S; Gousse, A; Keppenne, V; Aliotta, P; Sievert, KD; Brin, MF; Jenkins, B; Thompson, C; Lam, W; Heesakkers, J; Haag Molkenteller, C;
PUBLISHED: 2014, SOURCE: ADVANCES IN THERAPY, VOLUME: 31, ISSUE: 2
AUTHORS: Ginsberg, D; Cruz, F ; Herschorn, S; Gousse, A; Keppenne, V; Aliotta, P; Sievert, KD; Brin, MF; Jenkins, B; Thompson, C; Lam, W; Heesakkers, J; Haag Molkenteller, C;
PUBLISHED: 2014, SOURCE: ADVANCES IN THERAPY, VOLUME: 31, ISSUE: 2
2
TITLE: OnabotulinumtoxinA is Effective in Patients with Urinary Incontinence due to Neurogenic Detrusor Activity Regardless of Concomitant Anticholinergic Use or Neurologic Etiology Full Text
AUTHORS: Ginsberg, D; Cruz, F ; Herschorn, S; Gousse, A; Keppenne, V; Aliotta, P; Sievert, KD; Brin, MF; Jenkins, B; Thompson, C; Lam, W; Heesakkers, J; Haag Molkenteller, C;
PUBLISHED: 2013, SOURCE: ADVANCES IN THERAPY, VOLUME: 30, ISSUE: 9
AUTHORS: Ginsberg, D; Cruz, F ; Herschorn, S; Gousse, A; Keppenne, V; Aliotta, P; Sievert, KD; Brin, MF; Jenkins, B; Thompson, C; Lam, W; Heesakkers, J; Haag Molkenteller, C;
PUBLISHED: 2013, SOURCE: ADVANCES IN THERAPY, VOLUME: 30, ISSUE: 9
